Showing results (531-540 of 586) with videos related to

Sort By:
Pageof 59
Plos One|April 12, 2016
Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study)Eva Talavera-Garcia, Javier Delgado-Lista, Antonio Garcia-Rios, et al.
European Journal of Nutrition|July 26, 2019
Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trialGracia Maria Quintana-Navarro, Juan Francisco Alcala-Diaz, Javier Lopez-Moreno, et al.
Cannabis and Cannabinoid Research|July 21, 2022
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-AnalysisVera Belgers, Jantine G Röttgering, Linda Douw, et al.
Atherosclerosis|August 16, 2011
Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolismAntonio Garcia-Rios, Javier Delgado-Lista, Pablo Perez-Martinez, et al.
The American Journal of Medicine|January 3, 2015
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-upSami M A Alnasser, Wei Huang, Joel M Gore, et al.
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
Mitochondrial DNA. Part B, Resources|January 21, 2021
The complete mitochondrial genome of Xiphister atropurpureus (Perciformes: Stichaeidae), Laura Ayala, Joseph Becerra, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerationsJ Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
Investigational New Drugs|January 20, 2018
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancerAndreas Schneeweiss, Tjoung-Won Park-Simon, Joan Albanell, et al.
Pageof 59